Table 3.
Clinical Guidance Given and Organizational Guidance Received
| All Counselors | Counselors by Country | ||
|---|---|---|---|
| % (95% CI) | Canada N=29 % (95% CI) | US N=389 % (95% CI) | |
| Have any callers/clients asked you about e-cigarettes? (n=417) | |||
| Yes | 99.3 (98.5–100) | 100 | 99.2 (98.4–100) |
| Recommended e-cigarettes to a caller/client as a way to quit smoking? (n=402) | |||
| Yes | 4.0 (2.1–5.9) | 3.4 (0–10.1) | 4.0 (2.0–6.0) |
| Recommended e-cigarettes to a caller/client as a way to reduce the number of cigarettes smoked? (n=401) | |||
| Yes | 8.5 (5.7–11.2) | 3.4 (0–10.1) | 8.9 (6.0–11.8) |
| Ever asked someone in your professional circle about how to talk to a quitline caller about e-cigarettes? (n=402) | |||
| Yes | 78.6 (74.6–82.6) | 82.8 (69.0–96.6) | 78.3 (74.1–82.5) |
| If yes, who did you ask? (Choose all that apply) (n=316) | |||
| Peer | 56.3 (50.9–61.8) | 72.7 (54.9–90.5) | 55.5 (49.8–61.2) |
| Immediate supervisor | 74.4 (69.6–79.2) | 91.7 (80.7–100)* | 72.9 (67.8–78.0) |
| Clinical/Medical Director of your quitline | 36.4 (31.1–41.7) | 20.8 (4.6–37.0) | 37.7 (32.1–43.3) |
| Senior Management | 14.9 (11.0–18.8) | 25.0 (7.7–42.3) | 14.0 (10.0–18.0) |
| Other | 11.1 (7.6–14.5) | 4.2 (0–12.2) | 11.6 (7.9–15.3) |
| Has your employer provided instruction on how to talk with callers about e-cigarettes? (n=401) | |||
| Yes | 91.3 (88.5–94.0) | 100 | 90.6 (87.6–93.6) |
| What kind of instruction have you received? (Choose all that apply) (n=367) | |||
| Explain that e-cigarettes aren't FDA approved | 96.7 (94.9–98.6) | 96.6 (90.0–100) | 97.0 (95.2–98.8) |
| Support callers using e-cigarettes if they want | 44.4 (39.3–49.5) | 34.5 (17.2–51.8) | 45.4 (40.1–50.7) |
| Recommend other medications instead (e.g. NRT) | 73.8 (69.3–78.3) | 82.8 (69.1–96.5) | 73.3 (68.6–78.0) |
| Encourage use of e-cigarettes for harm reduction | 10.1 (7.0–13.2) | 10.3 (0–21.4) | 10.4 (7.1–13.7) |
| Other | 16.4 (12.6–20.1) | 10.3 (0–21.4) | 16.9 (12.9–20.9) |
*
p<0.05